These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6253826)

  • 1. A new class of angiotensin-converting enzyme inhibitors.
    Patchett AA; Harris E; Tristram EW; Wyvratt MJ; Wu MT; Taub D; Peterson ER; Ikeler TJ; ten Broeke J; Payne LG; Ondeyka DL; Thorsett ED; Greenlee WJ; Lohr NS; Hoffsommer RD; Joshua H; Ruyle WV; Rothrock JW; Aster SD; Maycock AL; Robinson FM; Hirschmann R; Sweet CS; Ulm EH; Gross DM; Vassil TC; Stone CA
    Nature; 1980 Nov; 288(5788):280-3. PubMed ID: 6253826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketomethyldipeptides I. A new class of angiotensin converting enzyme inhibitors.
    Natarajan S; Gordon EM; Sabo EF; Godfrey JD; Weller HN; Pluscec J; Rom MB; Cushman DW
    Biochem Biophys Res Commun; 1984 Oct; 124(1):141-7. PubMed ID: 6093782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin converting enzyme inhibitors: N-substituted D-glutamic acid gamma dipeptides.
    Ksander GM; Yuan AM; Diefenbacher CG; Stanton JL
    J Med Chem; 1985 Nov; 28(11):1606-11. PubMed ID: 2999395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
    Sweet CS
    Fed Proc; 1983 Feb; 42(2):167-70. PubMed ID: 6295819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors: synthesis and biological activity of acyl tripeptide analogues of enalapril.
    Greenlee WJ; Allibone PL; Perlow DS; Patchett AA; Ulm EH; Vassil TC
    J Med Chem; 1985 Apr; 28(4):434-42. PubMed ID: 2984419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual metalloprotease inhibitors. 6. Incorporation of bicyclic and substituted monocyclic azepinones as dipeptide surrogates in angiotensin-converting enzyme/neutral endopeptidase inhibitors.
    Robl JA; Cimarusti MP; Simpkins LM; Brown B; Ryono DE; Bird JE; Asaad MM; Schaeffer TR; Trippodo NC
    J Med Chem; 1996 Jan; 39(2):494-502. PubMed ID: 8558518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.
    Sweet CS; Gross DM; Arbegast PT; Gaul SL; Britt PM; Ludden CT; Weitz D; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):558-66. PubMed ID: 6259323
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo.
    Lew RA; Tomoda F; Evans RG; Lakat L; Boublik JH; Pipolo LA; Smith AI
    Br J Pharmacol; 1996 Jul; 118(5):1269-77. PubMed ID: 8818353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors: synthesis and structure-activity relationships of potent N-benzyloxycarbonyl tripeptide inhibitors.
    Sawayama T; Tsukamoto M; Sasagawa T; Nishimura K; Yamamoto R; Deguchi T; Takeyama K; Hosoki K
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2417-22. PubMed ID: 2605684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of conformationally constrained angiotensin-converting enzyme inhibitors.
    Weller HN; Gordon EM; Rom MB; Pluscec J
    Biochem Biophys Res Commun; 1984 Nov; 125(1):82-9. PubMed ID: 6095846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.
    Brunner DB; Desponds G; Biollaz J; Keller I; Ferber F; Gavras H; Brunner HR; Schelling JL
    Br J Clin Pharmacol; 1981 May; 11(5):461-7. PubMed ID: 6268131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic (hydroxyphosphinyl)acyl dipeptides: a new class of angiotensin converting enzyme inhibitors.
    Weller HN; Rom MB
    J Enzyme Inhib; 1988; 2(3):183-98. PubMed ID: 3071574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
    Laubie M; Schiavi P; Vincent M; Schmitt H
    J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
    Kaplan HR; Cohen DM; Essenburg AD; Major TC; Mertz TE; Ryan MJ
    Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
    Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H
    J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitor.
    Ryan MJ; Boucher DM; Cohen DM; Essenburg AD; Major TC; Mertz TE; Olszewski BJ; Randolph AE; Singer RM; Kaplan HR
    J Pharmacol Exp Ther; 1984 Feb; 228(2):312-8. PubMed ID: 6319675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive profile of the angiotensin-converting enzyme inhibitors CI-906 and CI-907.
    Ryan MJ; Boucher DM; Cohen DM; Olszewski BJ; Singer RM; Smith RD; Kaplan HR
    Fed Proc; 1984 Apr; 43(5):1330-2. PubMed ID: 6323224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silanediol inhibitors of angiotensin-converting enzyme. Synthesis and evaluation of four diastereomers of Phe[Si]Ala dipeptide analogues.
    Kim J; Hewitt G; Carroll P; Sieburth SM
    J Org Chem; 2005 Jul; 70(15):5781-9. PubMed ID: 16018669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
    Fink CA; Carlson JE; McTaggart PA; Qiao Y; Webb R; Chatelain R; Jeng AY; Trapani AJ
    J Med Chem; 1996 Aug; 39(16):3158-68. PubMed ID: 8759637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.